United Capital Financial Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-11,262	Closed	-$275K	–	1197
2021 Q2	$275K	Sell	11,262 -4,350	-28%	-$98.2K	﹤0.01%	1049
2021 Q1	$403K	Sell	15,612 -626	-4%	-$27.6K	﹤0.01%	911
2020 Q4	$868K	Sell	16,238 -3,661	-18%	-$182K	0.01%	712
2020 Q3	$821K	Buy	19,899 +1,051	+6%	+$45.4K	0.01%	708
2020 Q2	$914K	Buy	18,848 +403	+2%	+$19.3K	0.01%	688
2020 Q1	$779K	Sell	18,445 -317	-2%	-$13.1K	0.01%	692
2019 Q4	$803K	Hold	18,762	–	–	0.01%	849
2019 Q3	$675K	Buy	+18,762	New	+$569K	﹤0.01%	859
2017 Q1	–	Sell	-6,989	Closed	-$202K	–	1238
2016 Q4	$202K	Sell	6,989 -5,158	-42%	-$136K	﹤0.01%	1184
2016 Q3	$386K	Sell	12,147 -620	-5%	-$21K	﹤0.01%	1018
2016 Q2	$409K	Buy	+12,767	New	+$427K	﹤0.01%	963